Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

If You Have Fournier’s Gangrene and Have Taken Jardiance, You May Be entitled to Compensation

Introduction

Jardiance[1] is an oral diabetes medication that is used in conjunction with exercise and other programs to assist people with type two diabetes in regulating their blood sugar levels. It is in SGLT2 inhibitors, which is a sodium-glucose code transporter 2 inhibitors.[2]

What is Fournier’s Gangrene?

SGLT2 inhibitors lower blood sugar by causing the kidneys to remove the sugar from the body through urine. The bacteria feeds on the excessive amounts of sugar being excreted by the kidneys through the urethra. Typically, the bacteria enter through a cut or a wound at or near the site of exit on the body. This type of bacteria is known as Fournier’s Gangrene[3], which is a flesh-eating bacteria. Once the bacteria enters the body, it begins infecting the skin and immediately destroying it. The severity of the injuries caused by this type of bacteria can be fatal if not treated immediately.

When was the warning label issued?

In August 2018, the FDA[4] issued a warning providing that some of the type two diabetes medications, such as Jardiance, had been linked to the deadly illness in the genital area known as Fournier’s Gangrene, which is the signature injury of the Jardiance lawsuit. Some of the symptoms of Fournier’s Gangrene include fever, severe pain, and swelling in the perineal areas, followed by an odor of decaying tissue.

Michael Brady Lynch Firm

If you or a loved one have contracted the deadly bacterial disease, Fournier’s Gangrene, and have taken Jardiance in the time prior to the recall in August 2018, then you may be entitled to compensation. Please call us here at the Michael Brady Lynch Firm at 888-585-5970.

Date: August 18, 2022

Author: Brandon Salter

 

[1] Jardiance Lawsuit – Prescription Drug Journal™

[2] Fournier Gangrene Associated With Sodium–Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases: Annals of Internal Medicine: Vol 170, No 11 (acpjournals.org)

[3] Fournier Gangrene – NORD (National Organization for Rare Disorders) (rarediseases.org)

[4] Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors | FDA

Injured on a Cruise Ship? Call Us

Injured on a Cruise Ship? Call Us

Cruise vacations promise relaxation and adventure, but accidents do happen. Injuries aboard cruise ships can range from minor incidents to severe accidents, raising complicated legal questions about liability and compensation.

read more
Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

According to the National Center for Biotechnology Medicine, more people die from drug overdoses in the US than any other form of accidental death. Opioid overdoses outnumber the historical peak death rate of HIV, gun violence, and car crashes. There’s no doubt we’re in the middle of an opioid crisis. Often, people become addicted to this drug after a legitimate prescription to manage pain after surgery or a chronic pain condition.

read more
Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Over the past 20 to 30 years, studies and mainstream media outlets have blamed video games for desensitizing minors to violence, increased obesity rates, sedentary lifestyles, and mental health issues like depression and anxiety. Now, developers are facing video game lawsuits from gamers who have become addicted to video games. Learn more about video game addiction and what to do if you or a loved one have suffered from video game addiction below.

read more
Ozempic Lawsuit 2024: The Latest Updates

Ozempic Lawsuit 2024: The Latest Updates

The FDA has approved Ozempic, a medication manufactured by Dutch company Novo Nordisk, for treating type 2 diabetes. Many healthcare providers also prescribe Ozempic to their patients for weight management purposes. This is because the medication’s active ingredient, semaglutide, has been approved for weight loss treatments.

read more
PFAS Lawsuit Update: March 2024

PFAS Lawsuit Update: March 2024

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
×
What Our Clients Are Saying